Composition : Oxymetazoline Hydrochloride Nasal Solution I.P.
Packing : 10 ML
MRP : 95/-
Enquire NowOxivibe Nasal Drops is an adult nasal decongestant containing Oxymetazoline Hydrochloride I.P. 0.05% w/v. The product is supplied in a convenient 10 mL nasal-drop presentation.
Oxymetazoline is a topical nasal decongestant that acts on the blood vessels in the nasal passages, helping reduce swelling of the nasal membranes and temporarily relieve nasal congestion. Oxymetazoline 0.05% nasal formulations are commonly indicated for temporary relief of congestion associated with the common cold, hay fever and upper respiratory allergies, and may also provide temporary relief from sinus congestion and pressure.
Oxivibe is positioned as an adult-focused ENT and nasal-care product, making it a relevant addition to pharmaceutical portfolios serving respiratory and ENT segments.
Oxivibe Nasal Drops are used for the temporary relief of nasal congestion.
Oxymetazoline Hydrochloride helps shrink swollen nasal membranes, which can improve airflow through the nose. Oxymetazoline 0.05% nasal products are used for temporary relief of nasal congestion associated with common cold, hay fever and upper respiratory allergies, and can also temporarily relieve sinus congestion and pressure.
The product is marked For Adults on the supplied pack and should be used according to the approved product information and healthcare-professional guidance.
| Particular | Details |
|---|---|
| Brand Name | Oxivibe |
| Generic Name | Oxymetazoline Hydrochloride |
| Formulation | Oxymetazoline Hydrochloride Nasal Solution I.P. |
| Strength | 0.05% w/v |
| Dosage Form | Nasal Drops |
| Pack Size | 10 mL |
| Intended Users | Adults |
| Product Category | Nasal Decongestant |
| Therapeutic Segment | ENT / Nasal Care / Respiratory Care |
| Company | Farlex Pharmaceuticals Pvt. Ltd. |
Oxymetazoline is a topical nasal decongestant that causes vasoconstriction in the nasal mucosa. This action helps reduce swelling of the nasal membranes and temporarily improves nasal airflow.
This mechanism makes Oxivibe relevant for short-term management of nasal congestion where a topical nasal decongestant is appropriate.
The ENT and respiratory-care segment represents an important category within pharmaceutical product portfolios. Nasal decongestants provide a focused product option for businesses serving healthcare channels where temporary relief of nasal congestion is required.
Oxivibe Nasal Drops can be considered by PCD pharma franchise partners, pharmaceutical distributors, stockists, super stockists and pharma marketers looking to expand their ENT and nasal-care portfolio.
Its 0.05% Oxymetazoline Hydrochloride formulation, adult positioning and 10 mL nasal-drop presentation provide a straightforward addition to a specialized ENT product range.
Oxivibe offers:
Pack Size: 10 mL
Dosage Form: Nasal Drops
Strength: 0.05% w/v
Pack Positioning: For Adults
The latest approved product specification should be referred to for final commercial, regulatory and ordering information.
Oxivibe Nasal Drops may be relevant for:
Looking to add an Oxymetazoline Hydrochloride Nasal Decongestant to your pharmaceutical portfolio?
Connect with Farlex Pharmaceuticals Pvt. Ltd. for product availability, commercial details, business partnership opportunities and applicable product-range information.
Enquire Now for Product & Business Details.
Oxymetazoline nasal decongestants are generally intended for short-term use. Prolonged or frequent use can cause nasal congestion to recur or worsen, so the product should be used only according to the approved label
Send Enquiry
ISO, WHO And GMP Certified
(For Pharma Franchise & Third Party)
Copyright @ Farlex. Designed By Rednirus Digital Media